Last reviewed · How we verify
NCT06023654
Identifying Circadian Rest-Activity Rhythm Disorders in Patients With Advanced Cancer
trial in Cancer in 100 participants. Completed in 22 May 2024.
15 May 2024
Quick facts
| Lead sponsor | University of Dublin, Trinity College |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 15 May 2023 |
| Primary completion | 15 May 2024 |
| Estimated completion | 22 May 2024 |
| Sites | 2 locations across Ireland |
Conditions studied
- Cancer — all drugs for Cancer →
- Circadian Rhythm Disorders — all drugs for Circadian Rhythm Disorders →
- Sleep Disturbance — all drugs for Sleep Disturbance →
- Activity, Motor — all drugs for Activity, Motor →
Sponsor
University of Dublin, Trinity College
Who can join
18 and older, any sex, with Cancer or Circadian Rhythm Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Circadian rest-Activity Rhythm disorders (CARDs) are common in patients with cancer, particularly in advanced disease. CARDs are associated with increased symptoms, poorer quality of life, poorer response to anticancer treatments and shorter survival. The goal of this observational study is to see how common CARDs are in patients with advanced cancer and to characterise their rest and activity patterns in more detail. A recent study has outlined a standard way to assess and diagnose a CARD. This study aims to assess patients with advanced cancer for a CARD using a novel screening tool against this newly formed diagnostic criteria. Potentially modifiable risk factors will be considered along with associations between CARDs and symptoms, sleep preferences, sleep quality, daytime sleepiness, quality of life measures and predictors of survival.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Circadian rest-activity rhythm disorders in advanced cancer: assessment, diagnosis and clinical correlates.
Gouldthorpe C, Davies AN. · · 2025 · PMID 41043860 · DOI 10.1136/spcare-2025-005410
Verify or expand the search:
- PubMed search for NCT06023654
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other University of Dublin, Trinity College trials
Trials by the same sponsor.
- NCT07581093 — The REACT Study: REhabilitation and ACTivity in Allogenic Transplant · not yet recruiting
- NCT07393880 — Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal Tinnitus · NA · recruiting
- NCT07196020 — Prediction of Venous Thrombosis During chemotherapy-the PINPOINT Study · not yet recruiting
- NCT06280885 — A Flexible Individualized ExeRcise Programme for Cancer Patients During ChEmotherapy · NA · recruiting
- NCT06820008 — Measurement and Impact of Physical Impairment in Amyotrophic Lateral Sclerosis: Use of Digital Technologies - A Precisio · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06023654 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Dublin, Trinity College
- Last refreshed: 3 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06023654.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing